Coronary Artery Disease Clinical Trial
— R-EVOLUTIONOfficial title:
R-One Efficiency For PCI Evolution With Robotic Assistance
Verified date | February 2022 |
Source | Robocath |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a Prospective, Multi-center, Single-arm clinical study, in patients with Coronary Artery Disease, including patients with silent ischemia (excluding STEMI), who qualify for elective Percutaneous Coronary Intervention (PCI), aimed to assess the Safety and Efficacy of the R-One device in elective PCI.
Status | Completed |
Enrollment | 62 |
Est. completion date | December 15, 2021 |
Est. primary completion date | November 8, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age =18 years; - Candidate for PCI; - Presence of a de novo coronary artery stenosis of = 50% and <100% in a native coronary artery indicated and suitable for stent implantation; - The vessel has a reference vessel diameter ranging from 2.5 mm to 4.0 mm; - The target lesion length allows for treatment with a single stent up to 38 mm in length; - Up to 2 target vessels each with a single target lesion requiring a single stent per lesion and treatable within a single procedure may be included (no further staged procedure allowed); - The patient provides written informed consent as approved by the applicable Ethics Committee and is willing to comply with all study requirements including 30 days follow-up. Exclusion Criteria: - Target lesion has TIMI flow < 3; - Treatment of in-stent restenosis, or prior stent in the target vessel proximal to the target lesion; - More than one target lesion per vessel requiring treatment at the time of procedure; - Target lesion is a bifurcation requiring balloon or stent implantation of the side branch, with a side-branch RVD of =1.5 mm with a DS =50% at or within 5 mm its origin, or RVD =2.0 mm regardless of the presence of side branch disease; - Target lesion is located in left main coronary artery, or any left main stenosis > 30%; - Target lesion is within 5 mm of the ostial LAD, ostial LCX or ostial RCA; - Severe vessel tortuosity; - Severe vessel calcification; - STEMI, cardiopulmonary resuscitation or cardiogenic shock within 48 hours of the procedure; - Presence of visible thrombus; - Need for any procedure other than balloon angioplasty or stenting (e.g. atherectomy, laser, are excluded); - Patients under judicial protection, tutorship or curatorship (for France only); - Any patient participating in another clinical study evaluating a drug or a medical device (except registries for which the primary endpoint has not been evaluated; - Pregnant and breast-feeding women or intention to become pregnant prior to completion of all follow-up procedures. |
Country | Name | City | State |
---|---|---|---|
Belgium | Het Ziekenhuisnetwerk Antwerpen vzw | Antwerpen | |
France | CHU Caen Normandie | Caen | |
France | CHU Rouen | Rouen | |
France | Clinique Pasteur | Toulouse | |
Luxembourg | INCCI | Luxembourg | |
Netherlands | Maastad Ziekenhuis | Rotterdam |
Lead Sponsor | Collaborator |
---|---|
Robocath |
Belgium, France, Luxembourg, Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Safety Endpoint: Number of patients with absence of Intra-procedural complications (Dissection, Thrombus, Air embolus, traumatic aorta) | Absence of Intra-procedural complications (Dissection >/= NHLBI type D, perforation, decrease of TIMI flow (= 2), acute occlusion, visible thrombus formation, significant air embolus, traumatic aortic or Left Main dissection by guiding catheter | Peri-procedure | |
Primary | Efficacy Endpoint: Number of Patients with Procedure technical success | Procedure technical success defined as the successful advancement and retraction of all PCI devices (guidewires, balloon catheters and stents) and the successful treatment of all the target lesions using the R-One system and without conversion to manual operation | During Procedure | |
Secondary | Number of patients with Absence of each type of Intra-procedural complication (Dissection, Thrombus, Air embolus, traumatic aorta) | Component of the Primary Safety Endpoint: Absence of Intra-procedural complications (Dissection >/= NHLBI type D, perforation, decrease of TIMI flow (= 2), acute occlusion, visible thrombus formation, significant air embolus, traumatic aortic or Left Main dissection by guiding catheter | During Procedure | |
Secondary | Procedure duration | Time between arterial sheath introduction and sheath removal | During Procedure | |
Secondary | Robot duration | From the time when the robot begins to manipulate the guidewire to the time when the last guidewire is removed | During Procedure | |
Secondary | Radiation exposure using dosimeters (Patient Radiation, Robot Dose, Procedure Dose) | Patient and Operator | During Procedure | |
Secondary | Contrast Volume in mL | Measure of the volume of injected contrast media | During Procedure | |
Secondary | Rate of Bleeding or Vascular Complications | BARC definition | Up to 1 month | |
Secondary | Rate of Device Oriented Composite Criteria (Cardiovascular Death, Myocardial Infarction (peri-procedural and spontaneous), non clearly attributed to a non target or clinically driven target lesion revascularization) | ARC 2 definition: Cardiovascular Death, Myocardial Infarction (peri-procedural and spontaneous), non clearly attributed to a non target or clinically driven target lesion revascularization | Post-Procedure, 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |